Qualigen Therapeutics

$0.00 (0.00%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QLGN and other ETFs, options, and stocks.

About QLGN

Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARSâ„¢.

CEO
Michael S. Poirier
Employees
5
Headquarters
Los Angeles, California
Founded
2004

QLGN Key Statistics

Market Cap
33.93M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
126.88K
High Today
$1.20
Low Today
$1.12
Open Price
$1.19
Volume
246.77K
52 Week High
$4.78
52 Week Low
$1.12

QLGN Earnings

-$3.17
-$1.98
-$0.78
$0.41
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure